290 related articles for article (PubMed ID: 27251361)
1. Pretransplantation Donor-Recipient Pair Seroreactivity Against BK Polyomavirus Predicts Viremia and Nephropathy After Kidney Transplantation.
Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Mallat MJ; Haasnoot GW; van Zwet EW; Claas EC; de Fijter JW; Kroes AC; Arnold F; Touzé A; Claas FH; Rotmans JI; Feltkamp MC
Am J Transplant; 2017 Jan; 17(1):161-172. PubMed ID: 27251361
[TBL] [Abstract][Full Text] [Related]
2. Stability of BK polyomavirus IgG seroreactivity and its correlation with preceding viremia.
Wunderink HF; van der Meijden E; van der Blij-de Brouwer CS; Zaaijer HL; Kroes AC; van Zwet EW; Rotmans JI; Feltkamp MC
J Clin Virol; 2017 May; 90():46-51. PubMed ID: 28355579
[TBL] [Abstract][Full Text] [Related]
3. Impact of donor BK polyomavirus replication on recipient infections in living donor transplantation.
Grellier J; Hirsch HH; Mengelle C; Esposito L; Hebral AL; Bellière J; Weissbach F; Izopet J; Del Bello A; Kamar N
Transpl Infect Dis; 2018 Aug; 20(4):e12917. PubMed ID: 29800505
[TBL] [Abstract][Full Text] [Related]
4. Impact of HPyV9 and TSPyV coinfection on the development of BK polyomavirus viremia and associated nephropathy after kidney transplantation.
van Rijn AL; Wunderink HF; de Brouwer CS; van der Meijden E; Rotmans JI; Feltkamp MCW
J Med Virol; 2019 Jun; 91(6):1142-1147. PubMed ID: 30624811
[TBL] [Abstract][Full Text] [Related]
5. Reduced Risk of BK Polyomavirus Infection in HLA-B51-positive Kidney Transplant Recipients.
Wunderink HF; Haasnoot GW; de Brouwer CS; van Zwet EW; Kroes ACM; de Fijter JW; Rotmans JI; Claas FHJ; Feltkamp MCW
Transplantation; 2019 Mar; 103(3):604-612. PubMed ID: 30048396
[TBL] [Abstract][Full Text] [Related]
6. Urine Donor-Derived Cell-Free DNA Helps Discriminate BK Polyomavirus-Associated Nephropathy in Kidney Transplant Recipients With BK Polyomavirus Infection.
Chen XT; Chen WF; Li J; Deng RH; Huang Y; Yang SC; Chen PS; Jiang TY; Liu HT; Wang CX; Chen LZ; Qiu J; Huang G
Front Immunol; 2020; 11():1763. PubMed ID: 32973745
[No Abstract] [Full Text] [Related]
7. Pretransplantation seroreactivity in kidney donors and recipients as a predictive factor for posttransplant BKPyV-DNAemia.
Saláková M; Ludvíková V; Hamšíková E; Kolářová M; Šroller V; Viklický O; Wohlfahrtová M
Front Immunol; 2022; 13():929946. PubMed ID: 35967393
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of renal function after the first year of follow-up in kidney transplant recipients treated for significant BK polyomavirus infection or BK polyomavirus-associated nephropathy.
Simard-Meilleur MC; Bodson-Clermont P; St-Louis G; Pâquet MR; Girardin C; Fortin MC; Cardinal H; Hébert MJ; Lévesque R; Renoult E
Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207975
[TBL] [Abstract][Full Text] [Related]
9. Prediction of BK viremia by urine viral load in renal transplant patients: An analysis of BK viral load results in paired urine and plasma samples.
Madden K; Janitell C; Sower D; Yang S
Transpl Infect Dis; 2018 Oct; 20(5):e12952. PubMed ID: 29896858
[TBL] [Abstract][Full Text] [Related]
10. Early fulminant BK polyomavirus-associated nephropathy in two kidney transplant patients with low neutralizing antibody titers receiving allografts from the same donor.
Lorentzen EM; Henriksen S; Kaur A; Kro GB; Hammarström C; Hirsch HH; Midtvedt K; Rinaldo CH
Virol J; 2020 Jan; 17(1):5. PubMed ID: 31924245
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of and Risk Factors for BK Polyomavirus Replication and Nephropathy in Pediatric Renal Transplant Recipients: An International CERTAIN Registry Study.
Höcker B; Schneble L; Murer L; Carraro A; Pape L; Kranz B; Oh J; Zirngibl M; Dello Strologo L; Büscher A; Weber LT; Awan A; Pohl M; Bald M; Printza N; Rusai K; Peruzzi L; Topaloglu R; Fichtner A; Krupka K; Köster L; Bruckner T; Schnitzler P; Hirsch HH; Tönshoff B
Transplantation; 2019 Jun; 103(6):1224-1233. PubMed ID: 30130322
[TBL] [Abstract][Full Text] [Related]
12. Determination of viremia cut-off for risk to develop BKPyV-associated nephropathy among kidney transplant recipients.
Bicalho CS; Oliveira RDR; David DR; Fink MCDS; Agena F; Castro MC; Panutti C; David-Neto E; Pierrotti LC
Transpl Infect Dis; 2018 Oct; 20(5):e12969. PubMed ID: 30074295
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppression, BK polyomavirus infections, and BK polyomavirus-specific T cells after pediatric kidney transplantation.
Ahlenstiel-Grunow T; Pape L
Pediatr Nephrol; 2020 Apr; 35(4):625-631. PubMed ID: 31858227
[TBL] [Abstract][Full Text] [Related]
14. Variable sources of Bk virus in renal allograft recipients.
Urbano PRP; Nali LHDS; Oliveira RDR; Sumita LM; Fink MCDDS; Pierrotti LC; Bicalho CDS; David-Neto E; Pannuti CS; Romano CM
J Med Virol; 2019 Jun; 91(6):1136-1141. PubMed ID: 30680753
[TBL] [Abstract][Full Text] [Related]
15. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
Schwarz A; Linnenweber-Held S; Heim A; Framke T; Haller H; Schmitt C
Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
[TBL] [Abstract][Full Text] [Related]
16. Impact of HMG-CoA reductase inhibitors on the incidence of polyomavirus-associated nephropathy in renal transplant recipients with human BK polyomavirus viremia.
Gabardi S; Ramasamy S; Kim M; Klasek R; Carter D; Mackenzie MR; Chandraker A; Tan CS
Transpl Infect Dis; 2015 Aug; 17(4):536-43. PubMed ID: 25989423
[TBL] [Abstract][Full Text] [Related]
17. Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation.
Molnar MZ; Potluri VS; Schaubel DE; Sise ME; Concepcion BP; Forbes RC; Blumberg E; Bloom RD; Shaffer D; Chung RT; Strohbehn IA; Elias N; Azhar A; Shah M; Sawinski D; Binari LA; Talwar M; Balaraman V; Bhalla A; Eason JD; Besharatian B; Trofe-Clark J; Goldberg DS; Reese PP
Am J Transplant; 2022 Feb; 22(2):599-609. PubMed ID: 34613666
[TBL] [Abstract][Full Text] [Related]
18. Impact of Pretransplant Donor BK Viruria in Kidney Transplant Recipients.
Tan SK; Huang C; Sahoo MK; Weber J; Kurzer J; Stedman MR; Concepcion W; Gallo AE; Alonso D; Srinivas T; Storch GA; Subramanian AK; Tan JC; Pinsky BA
J Infect Dis; 2019 Jul; 220(3):370-376. PubMed ID: 30869132
[TBL] [Abstract][Full Text] [Related]
19. IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control study.
Tanriver U; Emmerich F; Hummel JF; Jänigen B; Panning M; Arnold F; Tanriver Y
Clin Transplant; 2022 Jul; 36(7):e14663. PubMed ID: 35368114
[TBL] [Abstract][Full Text] [Related]
20. BK polyomavirus infection after renal transplantation: Surveillance in a resource-challenged setting.
Bagchi S; Gopalakrishnan V; Srivastava SK; Upadhayay A; Singh G; Bhowmik D; Mahajan S; Dinda A; Agarwal SK
Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28834032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
